These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11494869)

  • 21. Probing the relative orientation of molecules bound to DNA by second-harmonic generation.
    Dadap JI; Eisenthal KB
    J Phys Chem B; 2014 Dec; 118(49):14366-72. PubMed ID: 25379958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues.
    Fan E; Shi W; Lowary TL
    J Org Chem; 2007 Apr; 72(8):2917-28. PubMed ID: 17373847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA recognition by the anthracycline antibiotic respinomycin D: NMR structure of the intercalation complex with d(AGACGTCT)2.
    Searle MS; Maynard AJ; Williams HE
    Org Biomol Chem; 2003 Jan; 1(1):60-6. PubMed ID: 12929391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
    Tevyashova A; Sztaricskai F; Batta G; Herczegh P; Jeney A
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4783-9. PubMed ID: 15324908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy.
    Robinson H; Priebe W; Chaires JB; Wang AH
    Biochemistry; 1997 Jul; 36(29):8663-70. PubMed ID: 9289011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring anthracycline binding to nucleotides by two dimensional cosy NMR experiments.
    Hammer BC; Russell RA; Warrener RN; Collins JG
    Biochem Int; 1991 Aug; 24(6):1075-84. PubMed ID: 1781786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the first parallel DNA quadruplex-drug complex.
    Clark GR; Pytel PD; Squire CJ; Neidle S
    J Am Chem Soc; 2003 Apr; 125(14):4066-7. PubMed ID: 12670225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A microscopic model of complex formation of intercalators with DNA: analysis of NMR spectroscopy data].
    Evstigneev MP; Beshnova DA; Rozvadovskaia AO
    Biofizika; 2008; 53(1):55-60. PubMed ID: 18488501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthracyclines-contra cruciform extrusion in DNA regulating sequences.
    Viglasky V
    Endocr Metab Immune Disord Drug Targets; 2006 Sep; 6(3):295-302. PubMed ID: 17017981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs.
    Jollès B; Laigle A; Priebe W; Garnier-Suillerot A
    Chem Biol Interact; 1996 Mar; 100(2):165-76. PubMed ID: 8646789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic and chemical footprinting of anthracycline antitumor antibiotics and related saccharide side chains.
    Shelton CJ; Harding MM; Prakash AS
    Biochemistry; 1996 Jun; 35(24):7974-82. PubMed ID: 8672501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone.
    Renneberg B; Li YM; Laatsch H; Fiebig HH
    Carbohydr Res; 2000 Dec; 329(4):861-72. PubMed ID: 11125829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural requirements for the formation of anthracycline-DNA adducts.
    Cutts SM; Parker BS; Swift LP; Kimura KI; Phillips DR
    Anticancer Drug Des; 2000 Oct; 15(5):373-86. PubMed ID: 11354313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of the antitumor drug nogalamycin to bulged DNA structures.
    Caceres-Cortes J; Wang AH
    Biochemistry; 1996 Jan; 35(2):616-25. PubMed ID: 8555235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in the field of antitumour anthracyclines.
    Monneret C
    Eur J Med Chem; 2001 Jun; 36(6):483-93. PubMed ID: 11525839
    [No Abstract]   [Full Text] [Related]  

  • 37. Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity.
    Gao YG; Priebe W; Wang AH
    Eur J Biochem; 1996 Sep; 240(2):331-5. PubMed ID: 8841395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative effects on the formation of intercalation sites.
    Trieb M; Rauch C; Wibowo FR; Wellenzohn B; Liedl KR
    Nucleic Acids Res; 2004; 32(15):4696-703. PubMed ID: 15342790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work.
    Martínez R; Chacón-García L
    Curr Med Chem; 2005; 12(2):127-51. PubMed ID: 15638732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of daunomycin complexed to d-TGATCA by two-dimensional nuclear magnetic resonance spectroscopy.
    Barthwal R; Sharma U; Srivastava N; Jain M; Awasthi P; Kaur M; Barthwal SK; Govil G
    Eur J Med Chem; 2006 Jan; 41(1):27-39. PubMed ID: 16293348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.